Raia Drogasil (OTCMKTS:RADLY) Releases Earnings Results, Meets Estimates

Raia Drogasil (OTCMKTS:RADLY) posted its quarterly earnings data on Tuesday. The company reported $0.05 EPS for the quarter, hitting the consensus estimate of $0.05, Zacks reports. Raia Drogasil had a net margin of 2.99% and a return on equity of 20.12%. The firm had revenue of $2.22 billion during the quarter, compared to analyst estimates of $2.41 billion.

Raia Drogasil Price Performance

Shares of Raia Drogasil stock traded down $0.12 on Wednesday, reaching $2.73. The company’s stock had a trading volume of 160 shares, compared to its average volume of 83,417. The company has a market capitalization of $3.58 billion and a P/E ratio of 18.17. Raia Drogasil has a 52-week low of $2.63 and a 52-week high of $5.34. The stock has a 50-day moving average price of $3.72 and a 200-day moving average price of $4.07. The company has a quick ratio of 0.58, a current ratio of 1.41 and a debt-to-equity ratio of 0.99.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group upgraded Raia Drogasil to a “buy” rating and set a $5.20 price target on the stock in a research note on Sunday, October 18th. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, Raia Drogasil currently has a consensus rating of “Moderate Buy” and an average price target of $5.20.

Raia Drogasil Company Profile

Raia Drogasil, now operating under the name RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a network of pharmacies offering prescription medicines, over-the-counter drugs, vitamins, personal care products, beauty items and other health-related merchandise.

The company also provides digital purchasing and delivery services through its online channels, supporting customers with prescription fulfillment, health products and related services. Its operations include pharmacy-based healthcare initiatives designed to complement its retail business and improve access to everyday healthcare.

RD Saúde was created in 2011 through the merger of Drogasil and Droga Raia, two established Brazilian pharmacy chains.